Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

The Feasibility and Therapeutic Effect of Hybrid End-effector Robot-assisted Gait Training With an Active-assisted Module in Chronic Stroke Survivors

NCT07034521 · National Taiwan University Hospital · Updated 19 May 2026

What is being tested
HIWIN MRG-P110
For
Stroke; Rehabilitation; Robotic Rehabilitation
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 60 people. The full rules are on the registry page.
Where
Taiwan
When
Starts or started 12 Aug 2025, ends May 2028. Registered 24 June 2025.
Results
None posted yet.

In the researchers' words

Walking rehabilitation after stroke is most effective during the first three months of recovery, but even in the chronic phase-beyond six months post-stroke-a significant number of patients still show potential for gait improvement. Robot-assisted rehabilitation is becoming increasingly common in clinical settings, with various design modes available. However, the effectiveness of new products in improving gait or motor function still requires further investigation. This study aims to evaluate the usability and therapeutic effects of a new end-effector exoskeleton robot system, HIWIN MRG-P110, for gait training in chronic stroke patients. The system uses foot pedal mechanisms to drive hip and knee movements for lower-limb training. Unlike its predecessor, this device allows adjustment of the active assistance ratio, encouraging users to engage in voluntary movement. It is designed for gait training in stroke patients and others with neurological impairments, but the usability and efficacy of this new training model remain to be verified. This clinical trial is a randomized, single-blind, prospective study enrolling 60 stroke patients who are 6 months to 3 years post-onset and have a Functional Ambulation Category (FAC) level of 0 to 3. The study will explore how patients with varying degrees of motor weakness learn to adapt to the "active-assistive mode" in terms of speed…
ClinicalTrials.gov, NCT07034521

Sites

  • National Taiwan University HospitalTaipei, Taipei, Taiwan